Traditional Chinese medicine injections with Activating Blood Circulation, equivalent effect of anticoagulation or antiplatelet, for acute myocardial infarction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
CONCLUSION: TCMi-ABC demonstrates additional clinical value in reducing mortality and the risk of malignant arrhythmia in patients with AMI. However, further validation of these findings is warranted through high-quality clinical trials due to methodological weaknesses in randomization, blinding, allocation concealment, and insufficient assessing for the purity/potency of herbs and the gram amount of active constituents.SYSTEMATIC REVIEW REGISTRATION: [INPLASY], identifier [INPLASY202170082].PMID:38616000 | DOI:10.1016/j.ctim.2024.103039
Source: Complementary Therapies in Medicine - Category: Complementary Medicine Authors: Xue-Yan Sun Jia-Ping Chen Ju-Ju Shang Hong-Xu Liu Xiang Li Yan Lou Hui-Wen Zhou Source Type: research
More News: Alternative and Complementary Therapies | Arrhythmia | Cancer & Oncology | China Health | Clinical Trials | Complementary Medicine | Databases & Libraries | Heart Attack | Herbs | Science | Sodium | Study